Panelius M, Myllylä G, Penttinen K, Halonen P, Rinne U K
Br Med J. 1970 May 23;1(5707):461-2. doi: 10.1136/bmj.2.5707.461.
With the measles platelet aggregation test, a new technique recently developed for measuring virus antibody, 153 serum specimens from patients with multiple sclerosis and 164 controls were tested. With one of the three measles antigens used in the test a significantly higher positive rate (P<0.001) was obtained in the specimens from the patients with multiple sclerosis (40%) than in those from the controls (11%). The other two measles antigens also yielded slightly but not significantly higher positive rates in the patients with multiple sclerosis.
采用最近开发的一种用于检测病毒抗体的新技术——麻疹血小板凝集试验,对153份来自多发性硬化症患者的血清标本和164份对照标本进行了检测。在该试验所使用的三种麻疹抗原中的一种上,多发性硬化症患者标本的阳性率(40%)显著高于对照标本(11%)(P<0.001)。另外两种麻疹抗原在多发性硬化症患者中的阳性率也略高,但无显著差异。